tradingkey.logo
tradingkey.logo
Search

Kalvista Pharmaceuticals Inc

KALV
Add to Watchlist
26.990USD
0.0000.00%
Close 07/10, 16:00ETQuotes delayed by 15 min
1.44BMarket Cap
LossP/E TTM

Kalvista Pharmaceuticals Inc's Company Valuation

Currency: USD Updated: 2026-06-10
Previous score
8.97
Change
0
The current valuation score of Kalvista Pharmaceuticals Inc is 8.97, ranking 56 out of 390 in the Biotechnology & Medical Research industry. Its current P/E ratio is -62.75, which is -97.85% below the recent high of -1.35 and 0.00% above the recent low of -62.75.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.